The Federal University of Minas Gerais is a federal research university located in the state of Minas Gerais. Its main and biggest campus is located at the city of Belo Horizonte, Brazil. It is one of Brazil's five largest and best universities, being the largest federal university.

During the past decade, Federal University of Minas Gerais conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 1 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Federal University of Minas Gerais" #1 sponsor was "Federal University of Minas Gerais" with 21 trials, followed by "Butantan Institute" with 3 trials sponsored, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials sponsored, "University of Sao Paulo" with 2 trials sponsored and "Bausch & Lomb Incorporated" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federal University of Minas Gerais" #1 collaborator was "Fundação de Amparo à Pesquisa do estado de Minas Gerais" with 5 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 4 trials as a collaborator, "Coordenação de Aperfeiçoamento de Pessoal de Nível Superior." with 4 trials as a collaborator, "Federal University of Minas Gerais" with 3 trials as a collaborator and "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 2 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Federal University of Minas Gerais" are "COVID-19" (3 trials), "Anxiety" (2 trials), "Chagas Disease" (2 trials), "Coronary Disease" (2 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Federal University of Minas Gerais" in a lesser frequency.

Most popular intervention types in "Federal University of Minas Gerais" are "Other" (16 trials), "Behavioral" (6 trials), "Drug" (6 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Questionnaires" (2 trials), "10% PVPI degermante" (1 trials), "4% Chlorhexidine gluconate" (1 trials) and "Acupuncture" (1 trials). Other intervention names were less common.

The vast majority of trials in "Federal University of Minas Gerais" are 33 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Federal University of Minas Gerais". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Federal University of Minas Gerais, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Federal University of Minas Gerais, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 18 trials that are defined as “Not Applicable".

Federal University of Minas Gerais has several departments that took part in Clinical trials: "Laboratório de Avaliação e Pesquisa em Desempenho Cardiorrespiratório da UFMG" - 3 trials, "Federal University of Minas, Dept. of Pediatrics" - 2 trials, "Department of Physical Therapy, Universidade Federal de Minas Gerais" - 2 trials, "Universidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Cirurgia." - 2 trials, "Instituto Alfa de Gastroenterologia" - 2 trials